Talk:BOD: Difference between revisions

>Psychonaut007
changed the molecule picture from DMT to BOD
>Dextromethorphan
updated article
Line 2: Line 2:
{{headerpanel|{{Approval}}}}
{{headerpanel|{{Approval}}}}
{{SummarySheet}}
{{SummarySheet}}
{{SubstanceBox
{{SubstanceBox/BOD}}


    <!-- Special Parameters -->
'''4-methyl-2,5,beta-trimethoxyphenethylamine''' (also known as '''BOD''' ) is a lesser-known [[psychoactive class::psychedelic]] and [[psychoactive class::entactogen]] substance of the [[chemical class::phenethylamine]] class. BOD is a member of the [[chemical class::BOx]] family of compounds which are relatively unknown, and have only recently found sales in the [[research chemical]] community.  
    |displayClasses={{{displayClasses|}}}
    |MaterialTable_MaxWidth=250px
    |MaterialTable_Title={{PAGENAME}}
 
    <!-- Modules -->
    |ModuleSource=false
    |ModuleCombination=false
    |ModuleStructure=true
    |ModuleNomenclature=true
    |ModuleClassMembership=true
    |ModuleROA=true
 
    <!-- Source -->
    |PhotoImageFile=
    |PhotoImageWidth=
    |PhotoImageCaption=
 
    <!-- Combination -->
    |CombinationImage1_Caption=
    |CombinationImage1_File=
    |CombinationImage1_Width=
 
    |CombinationImage2_Caption=
    |CombinationImage2_File=
    |CombinationImage2_Width=
 
    |CombinationImage3_Caption=
    |CombinationImage3_File=
    |CombinationImage3_Width=
 
    <!-- Structure -->
    |MolecularStructureCaption=Molecular structure of BOD
    |SkeletalImageFile=File:BOD.svg
    |SkeletalImageWidth=245px
    |3DImageFile=
    |3DImageWidth=
 
    <!-- Nomenclature -->
    |NameCommon=BOD
    |NameSubstitution=4-methyl-2,5,beta-trimethoxyphenethylamine
    |NameSystematic=2-(2,5-Dimethoxy-4-methylphenyl)-2-methoxyethan-1-amine
 
    <!-- Class Membership -->
    |EffectClass=[[psychoactive class::Psychedelic]]
    |ChemicalClass=[[chemical class::Phenethylamine]]
 
    <!-- Dosage/Duration per ROA -->
 
    |OralROA=false
    |OralROA_Collapsed=true
    |OralROA_Caption=
    |OralROA_Bioavailability=
    |OralROA_Threshold=
    |OralROA_Light=
    |OralROA_Common=
    |OralROA_Strong=
    |OralROA_Heavy=
    |OralROA_TimelineFile=
    |OralROA_TimelineWidth=
    |OralROA_Duration=
    |OralROA_Onset=
    |OralROA_Comeup=
    |OralROA_Peak=
    |OralROA_Offset=
    |OralROA_Aftereffects=
 
    |BuccalROA=false
    |BuccalROA_Collapsed=true
    |BuccalROA_Caption=Presumes no tolerance
    |BuccalROA_Bioavailability=
    |BuccalROA_Threshold=< x mg
    |BuccalROA_Light=x - x mg
    |BuccalROA_Common=x - x mg
    |BuccalROA_Strong=x - x mg
    |BuccalROA_Heavy= >  mg
    |BuccalROA_TimelineFile=
    |BuccalROA_TimelineWidth=
    |BuccalROA_Duration=x - x hours
    |BuccalROA_Onset=x minutes
    |BuccalROA_Peak=x hours
    |BuccalROA_Offset=x hours
    |BuccalROA_Aftereffects=x hours
 
    |InsufflatedROA=false
    |InsufflatedROA_Collapsed=true
    |InsufflatedROA_Caption=
    |InsufflatedROA_Bioavailability=
    |InsufflatedROA_Threshold=< x mg
    |InsufflatedROA_Light=x - x mg
    |InsufflatedROA_Common=x - x mg
    |InsufflatedROA_Strong=x - x mg
    |InsufflatedROA_Heavy= >  mg
    |InsufflatedROA_TimelineFile=
    |InsufflatedROA_TimelineWidth=
    |InsufflatedROA_Duration=x - x hours
    |InsufflatedROA_Onset=x minutes
    |InsufflatedROA_Peak=x hours
    |InsufflatedROA_Offset=x hours
    |InsufflatedROA_Aftereffects=x hours
 
    |RectalROA=false
    |RectalROA_Collapsed=true
    |RectalROA_Caption=Presumes no tolerance
    |RectalROA_Bioavailability=
    |RectalROA_Threshold=< x mg
    |RectalROA_Light=x - x mg
    |RectalROA_Common=x - x mg
    |RectalROA_Strong=x - x mg
    |RectalROA_Heavy= >  mg
    |RectalROA_TimelineFile=
    |RectalROA_TimelineWidth=
    |RectalROA_Duration=x - x hours
    |RectalROA_Onset=x minutes
    |RectalROA_Peak=x hours
    |RectalROA_Offset=x hours
    |RectalROA_Aftereffects=x hours
 
    |TransdermalROA=false
    |TransdermalROA_Collapsed=true
    |TransdermalROA_Caption=Presumes no tolerance
    |TransdermalROA_Bioavailability=
    |TransdermalROA_Threshold=< x mg
    |TransdermalROA_Light=x - x mg
    |TransdermalROA_Common=x - x mg
    |TransdermalROA_Strong=x - x mg
    |TransdermalROA_Heavy= >  mg
    |TransdermalROA_TimelineFile=
    |TransdermalROA_TimelineWidth=
    |TransdermalROA_Duration=x - x hours
    |TransdermalROA_Onset=x minutes
    |TransdermalROA_Peak=x hours
    |TransdermalROA_Offset=x hours
    |TransdermalROA_Aftereffects=x hours
 
    |SubcutaneousROA=false
    |SubcutaneousROA_Collapsed=true
    |SubcutaneousROA_Caption=Presumes no tolerance
    |SubcutaneousROA_Bioavailability=
    |SubcutaneousROA_Threshold=< x mg
    |SubcutaneousROA_Light=x - x mg
    |SubcutaneousROA_Common=x - x mg
    |SubcutaneousROA_Strong=x - x mg
    |SubcutaneousROA_Heavy= >  mg
    |SubcutaneousROA_TimelineFile=
    |SubcutaneousROA_TimelineWidth=
    |SubcutaneousROA_Duration=x - x hours
    |SubcutaneousROA_Onset=x minutes
    |SubcutaneousROA_Peak=x hours
    |SubcutaneousROA_Offset=x hours
    |SubcutaneousROA_Aftereffects=x hours
 
    |IntramuscularROA=false
    |IntramuscularROA_Collapsed=true
    |IntramuscularROA_Caption=Presumes no tolerance
    |IntramuscularROA_Bioavailability=
    |IntramuscularROA_Threshold=< x mg
    |IntramuscularROA_Light=x - x mg
    |IntramuscularROA_Common=x - x mg
    |IntramuscularROA_Strong=x - x mg
    |IntramuscularROA_Heavy= >  mg
    |IntramuscularROA_TimelineFile=
    |IntramuscularROA_TimelineWidth=
    |IntramuscularROA_Duration=x - x hours
    |IntramuscularROA_Onset=x minutes
    |IntramuscularROA_Peak=x hours
    |IntramuscularROA_Offset=x hours
    |IntramuscularROA_Aftereffects=x hours
 
    |IntravenousROA=false
    |IntravenousROA_Collapsed=true
    |IntravenousROA_Caption=Presumes no tolerance
    |IntravenousROA_Bioavailability=
    |IntravenousROA_Threshold=< x mg
    |IntravenousROA_Light=x - x mg
    |IntravenousROA_Common=x - x mg
    |IntravenousROA_Strong=x - x mg
    |IntravenousROA_Heavy= >  mg
    |IntravenousROA_TimelineFile=
    |IntravenousROA_TimelineWidth=
    |IntravenousROA_Duration=x - x hours
    |IntravenousROA_Onset=x minutes
    |IntravenousROA_Peak=x hours
    |IntravenousROA_Offset=x hours
    |IntravenousROA_Aftereffects=x hours
 
}}
 
'''4-methyl-2,5,beta-trimethoxyphenethylamine''' (also known as '''BOD''' ) is a lesser-known [[psychoactive class::psychedelic]] and [[psychoactive class::entactogen]] substance of the [[chemical class::phenethylamine]] class. BOD is a member of the [[BOx]] family of compounds which are relatively unknown, and have only recently found sales in the research chemical community.  


BOD was first synthesized and tested  by [[Alexander Shulgin]].<ref name="BOD">Shulgin, Alexander (1991). PiHKAL: A Chemical Love Story. Berkeley, CA: Transform Press. pp. 53–56.</ref>  
BOD was first synthesized and tested  by [[Alexander Shulgin]].<ref name="BOD">Shulgin, Alexander (1991). PiHKAL: A Chemical Love Story. Berkeley, CA: Transform Press. pp. 53–56.</ref>  
It gained little popularity and even by 2019 it is still relatively unknown.From the few reports of it, BOD seems to be very much like the [[DOx]] family compounds in terms of it being dose sensitive, long lasting, intense, and very stimulating albeit much less potent. However, its chemical structure is related to compounds of the trimethoxyamphetamine class, and it may share a similar pharmacological profile to both.
It gained little popularity and even by 2019 it is still relatively unknown, mostly because it has largely disappeared from the market. From the few reports of it, BOD seems to be long lasting and stimulating.  


==History and culture==
==History and culture==
Line 202: Line 14:
==Chemistry==
==Chemistry==
BOD, or 4-methyl-2,5,beta-trimethoxyphenethylamine is a molecule of the [[substituted phenethylamine]] class. BOD was the first BOx compound shulgin studied and it is the beta-methoxy analog of [[2cd]]. Shulgin only looked into 4 [[BOx]] compounds of which only [[BOB]] and [[BOD]] were found to have psychedelic and entacteogenic effects.
BOD, or 4-methyl-2,5,beta-trimethoxyphenethylamine is a molecule of the [[substituted phenethylamine]] class. BOD was the first BOx compound shulgin studied and it is the beta-methoxy analog of [[2cd]]. Shulgin only looked into 4 [[BOx]] compounds of which only [[BOB]] and [[BOD]] were found to have psychedelic and entacteogenic effects.
==Pharmacology==
==Pharmacology==
{{pharmacology}}
{{pharmacology}}
BOD likely acts as a 5-HT2A agonist.


==Subjective effects==
==Subjective effects==
Most users describe BOD as being clearheaded and lucid at lower doses, in ways reminiscent of most 2cx's. At higher doses however the experience can become highly intense and in some cases produces unique effects which are not found in other [[psychoactive class::psychedelics]].
Most users describe BOD as being clearheaded and lucid at lower doses, in ways reminiscent of most [[2C-x]]. At higher doses however the experience can become highly intense and in some cases produces unique effects which are not found with other [[psychedelics]].
 
{{Preamble/SubjectiveEffects}}
{{Preamble/SubjectiveEffects}}
{{effects/base
{{effects/base


Line 222: Line 38:
}}
}}
{{effects/visual|
{{effects/visual|
The visual effects of BOD are more consistent and reproducible in a way comparable to [[DOM]], or [[2C-B]]. This effect becomes quite pronounced at higher doses as the cognitive effects and physical effects seem to combine with the visual producing a state that is unique among psychedelics.
The visual effects of BOD are more consistent and reproducible in a way comparable to [[DOM]], or [[2C-B]]. This effect becomes quite pronounced at higher doses as the cognitive effects and physical effects seem to combine with the visual producing a state that is unique among psychedelics.


====Enhancements====
====Enhancements====
Line 249: Line 65:


*'''[[Effect::Internal hallucinations]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::perspective hallucinations]]'' and ''[[effect::scenarios and plots]]'') - In comparison to other [[psychedelic]]s such as [[LSD]], BOD is extremely high in internal hallucinations when approaching higher dosages. They are more common within dark environments and can be comprehensibly described through its [[Internal_hallucinations#Variations|variations]] as lucid in believability, interactive in style, new experiences in content, autonomous in controllability, [[geometry]]-based in style and almost exclusively of a personal, religious, spiritual, science-fiction, fantasy, surreal, nonsensical or transcendental nature in their overall theme.
*'''[[Effect::Internal hallucinations]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::perspective hallucinations]]'' and ''[[effect::scenarios and plots]]'') - In comparison to other [[psychedelic]]s such as [[LSD]], BOD is extremely high in internal hallucinations when approaching higher dosages. They are more common within dark environments and can be comprehensibly described through its [[Internal_hallucinations#Variations|variations]] as lucid in believability, interactive in style, new experiences in content, autonomous in controllability, [[geometry]]-based in style and almost exclusively of a personal, religious, spiritual, science-fiction, fantasy, surreal, nonsensical or transcendental nature in their overall theme.
*'''[[Effect:: External hallucinations]]''' - These are often present during the peak and can are almost entirely [[geometry]]-based in style, with very little theme to them unlike the internal hallucinations. Due to BOD's long length the comedown of the substance can cause [[sleep deprivation]] which may lead to [[shadow people]], and [[unspeakable horrors]]
*'''[[Effect:: External hallucinations]]''' - These are often present during the peak and can are almost entirely [[geometry]]-based in style, with very little theme to them unlike the internal hallucinations. Due to BOD's long length the comedown of the substance can cause [[sleep deprivation]] which may lead to [[shadow people]], and [[unspeakable horrors]].


}}
}}
Line 257: Line 73:
You may select from a list of cognitive effects to add below [[Subjective effect index#Cognitive effects|here]].
You may select from a list of cognitive effects to add below [[Subjective effect index#Cognitive effects|here]].


*'''[[Effect::Empathy, affection and sociability enhancement]]''' -The entactogenic effects of BOD are much more pronounced than most psychedelics, and while not as strong as [[MDMA]], are stronger than other similar psychedelics, and are enough to produce therapeutic effects for certain people.
*'''[[Effect::Empathy, affection and sociability enhancement]]''' - The entactogenic effects of BOD are much more pronounced than most psychedelics, and while not as strong as [[MDMA]], are stronger than other similar psychedelics, and are enough to produce therapeutic effects for certain people.
*'''[[Effect::Increased sense of humor ]]''' -This is one of the more noticeable effects of BOD, and is more pronounced than most [[psychoactive class::psychedelics]]. Strangely it is very similar to the effects of cannabinoids such as [[cannabis]]
*'''[[Effect::Increased sense of humor]]''' - This is one of the more noticeable effects of BOD, and is more pronounced than most psychedelics. Strangely it is very similar to the effects of cannabinoids such as [[cannabis]].
*'''[[Effect::Emotion enhancement]]''' -While BOD produces a mostly euphoric state, like most psychedelics the high can change quite rapidly from euphoric to dysphoric merely due to emotional changes. This is an intense state which is less controllable than in other clear headed psychedelics and can feel quite strange and scary if one is unprepared.
*'''[[Effect::Emotion enhancement]]''' - While BOD produces a mostly euphoric state, like most psychedelics the high can change quite rapidly from euphoric to dysphoric merely due to emotional changes. This is an intense state which is less controllable than in other clear headed psychedelics and can feel quite strange and scary if one is unprepared.
*'''[[Effect::Analysis enhancement]]'''
*'''[[Effect::Analysis enhancement]]'''
*'''[[Effect::Conceptual thinking]]'''
*'''[[Effect::Conceptual thinking]]'''
Line 266: Line 82:
*'''[[Effect::Increased music appreciation]]'''
*'''[[Effect::Increased music appreciation]]'''
*'''[[Effect::Memory suppression]]'''
*'''[[Effect::Memory suppression]]'''
**'''[[Effect::Ego death]]''' - BOD produces a unique ego death that is not as much a loss in sense of self as it is the feeling as though one is a viewer of the world from an outside, in a way which is similar to but unique from compounds such as [[LSD]], and [[2C-B]]
**'''[[Effect::Ego death]]'''
*'''[[Effect::Personal bias suppression]]'''-
*'''[[Effect::Personal bias suppression]]'''
*'''[[Effect::Thought acceleration]]'''
*'''[[Effect::Thought acceleration]]'''
*'''[[Effect::Thought connectivity]]'''
*'''[[Effect::Thought connectivity]]'''
Line 302: Line 118:
}}
}}
===Experience reports===
===Experience reports===
There are currently {{#ask:[[Category:SUBSTANCE]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]].
There are currently {{#ask:[[Category:BOD]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]].
{{#ask: [[Category:BOD]][[Category:Experience]]|format=ul|Columns=1}}
{{#ask: [[Category:BOD]][[Category:Experience]]|format=ul|Columns=1}}
Additional experience reports can be found here:
Additional experience reports can be found here:
* [https://www.erowid.org/experiences/subs/exp_BOD.shtml Erowid Experience Vaults: BOD] <!-- Check the link to see if it exists -->
* [https://www.erowid.org/experiences/subs/exp_BOD.shtml Erowid Experience Vaults: BOD]


==Toxicity and harm potential==
==Toxicity and harm potential==
{{Toxicity}}
{{Toxicity}}
BOD has had such a limited history of us that as of 2019 while certain individuals are able to use as high as 70mg, and given the reduced potency compared to other long lasting [[psychoactive class::psychedelic]] it is most likely BOD has a toxicity profile comparable to the [[2Cx]] compounds. However given its strong dose response curve, the little information about the substance, and the long come up. It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance.
BOD has had such a limited history of us that as of 2019 while certain individuals are able to use as high as 70mg, and given the reduced potency compared to other long lasting [[psychoactive class::psychedelic]] it is most likely BOD has a toxicity profile comparable to the [[2Cx]] compounds. However given its strong dose response curve, the little information about the substance, and the long come up. It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance.
===Lethal dosage===
===Lethal dosage===
The highest dose consumed of BOD that has been reported so far is around 70mg. BOD has very little likihood of being a full agonist of 5-HT2A but that does not mean it is a purely safe psychedelic. While most dose ranges display common doses at 20-30mg, due to the substances response curve and its slow come up, the dose information currently available may not be correct, as other subtances Shulgin studied he found inactive were actually active at much higher doses.  
The highest dose consumed of BOD that has been reported so far is around 70mg. BOD has very little likihood of being a full agonist of 5-HT2A but that does not mean it is a purely safe psychedelic. While most dose ranges display common doses at 20-30mg, due to the substances response curve and its slow come up, the dose information currently available may not be correct, as other subtances Shulgin studied he found inactive were actually active at much higher doses.  
===Tolerance and addiction potential===
===Tolerance and addiction potential===
BOD is not habit-forming and the desire to use can actually decrease.
===Dangerous interactions===
===Dangerous interactions===
{{DangerousInteractions}}
{{DangerousInteractions}}
{{DangerousInteractions/Intro}}
{{DangerousInteractions/Intro}}
*'''[[Tramadol]]''' - Tramadol lowers the seizure threshold<ref>Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of medical toxicology, 5(2), 63-67. doi:10.1007/BF03161089</ref> and [[psychedelics]] may act as triggers for seizures, particularly in those who are predisposed to them.{{citation needed}}
{{DangerousInteractions/Psychedelics}}
*'''[[Stimulants]]''' - Stimulants affect many parts of the brain. Combined with psychedelics, stimulation can turn into uncontrollable [[anxiety]], [[Panic attacks|panic]], [[thought loops]] and [[paranoia]]. This interaction may cause elevated risk of psychosis.{{citation needed}}
*'''[https://en.wikipedia.org/wiki/Lithium_(medication) Lithium]''' - Lithium is often used as treatment for bipolar disorder. It may possibly cause elevated risk of seizures and psychosis due to its [[Glutamate|glutaminergic]] and [[GABA|GABAergic]] effects.{{citation needed}}
*'''[[Serotonin Syndrome]]''' - Although no research has shown any possible serotonin syndrome risks, given the fact that BOD has been studied so little it is advised
*'''[[Serotonin Syndrome]]''' - Although no research has shown any possible serotonin syndrome risks, given the fact that BOD has been studied so little it is advised


Line 332: Line 150:
*[https://erowid.org/library/books_online/pihkal/pihkal014.shtml BOD (Erowid Vault]
*[https://erowid.org/library/books_online/pihkal/pihkal014.shtml BOD (Erowid Vault]
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=14 BOD (Isomer Design)]
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=14 BOD (Isomer Design)]
==Literature==
* APA formatted reference
Please see the [[citation formatting guide]] if you need assistance properly formatting citations.


==References==
==References==
Return to "BOD" page.